nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 29th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
DECLINE_TO_STATE
|
Cambridge, MA
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:32PM
|
Aug 29th, 2022 12:32PM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 28th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
DECLINE_TO_STATE
|
Cambridge, MA
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:32AM
|
Aug 28th, 2022 05:32AM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 27th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
DECLINE_TO_STATE
|
Cambridge, MA
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 04:50AM
|
Aug 27th, 2022 04:50AM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 25th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
DECLINE_TO_STATE
|
Cambridge, MA
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 09:30AM
|
Aug 25th, 2022 09:30AM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 23rd, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
|
215 First Street Cambridge, MA 02142
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 11:23AM
|
Aug 23rd, 2022 11:23AM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 21st, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
|
215 First Street Cambridge, MA 02142
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 01:07PM
|
Aug 21st, 2022 01:07PM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 20th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
|
215 First Street Cambridge, MA 02142
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 02:45PM
|
Aug 20th, 2022 02:45PM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 19th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
|
215 First Street Cambridge, MA 02142
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 01:07PM
|
Aug 19th, 2022 01:07PM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 18th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
|
215 First Street Cambridge, MA 02142
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 04:51AM
|
Aug 18th, 2022 04:51AM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:sage
|
https://www.indeed.com/cmp/sage-therapeutics
|
Aug 17th, 2022 12:00AM
|
Open
|
SAGE Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
The human brain is the most complex organ of the human body. It is made up of an integrated network of approximately 100 billion nerve cells called neurons, connected in complex electrical circuits to communicate. Brain health and function depend on the interaction of these circuits. Navigating these complex circuits is a challenge, but a welcome opportunity for the teams at Sage as we seek to develop novel medicines.
Sage is a place where unconventional thinking to solve problems with new ideas is welcome – and where unconventional thinkers can imagine what’s possible and do big.
Read our Community Guidelines: http://bit.ly/2tFyAoj
|
|
215 First Street Cambridge, MA 02142
|
Barry Greene
|
|
|
4.40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.00
|
14.00
|
4.40
|
4.60
|
3.90
|
3.80
|
4.30
|
8.00
|
More than one month
|
10.00
|
MEDIUM
|
10.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 10:29AM
|
Aug 17th, 2022 10:29AM
|
Sage Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|